524735 Stock Overview
Manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, animal health, biotech, crop protection, and specialty chemicals companies in India, the United States, Canada, Europe, South East Asia, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
Hikal Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹392.20 |
| 52 Week High | ₹416.15 |
| 52 Week Low | ₹260.65 |
| Beta | 1.25 |
| 11 Month Change | 3.44% |
| 3 Month Change | 19.87% |
| 1 Year Change | 45.56% |
| 33 Year Change | -26.21% |
| 5 Year Change | 253.81% |
| Change since IPO | 38,267.51% |
Recent News & Updates
Recent updates
Shareholder Returns
| 524735 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 1.9% | -3.1% | -3.4% |
| 1Y | 45.6% | 41.1% | 27.0% |
Return vs Industry: 524735 exceeded the Indian Pharmaceuticals industry which returned 41.1% over the past year.
Return vs Market: 524735 exceeded the Indian Market which returned 27% over the past year.
Price Volatility
| 524735 volatility | |
|---|---|
| 524735 Average Weekly Movement | 6.0% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.2% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 524735 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 524735's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1988 | 2,061 | Sameer Hiremath | www.hikal.com |
Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, animal health, biotech, crop protection, and specialty chemicals companies in India, the United States, Canada, Europe, South East Asia, and internationally. It operates through two segments, Pharmaceuticals and Crop Protection. The Pharmaceuticals segment produces active pharmaceutical ingredients (APIs).
Hikal Limited Fundamentals Summary
| 524735 fundamental statistics | |
|---|---|
| Market cap | ₹49.37b |
| Earnings (TTM) | ₹736.02m |
| Revenue (TTM) | ₹18.21b |
65.7x
P/E Ratio2.7x
P/S RatioIs 524735 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 524735 income statement (TTM) | |
|---|---|
| Revenue | ₹18.21b |
| Cost of Revenue | ₹9.02b |
| Gross Profit | ₹9.20b |
| Other Expenses | ₹8.46b |
| Earnings | ₹736.02m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 5.97 |
| Gross Margin | 50.50% |
| Net Profit Margin | 4.04% |
| Debt/Equity Ratio | 64.2% |
How did 524735 perform over the long term?
See historical performance and comparison